Provider Education – GeneLit

Cross-sectional clinical cancer genomics community of practice survey analysis of provider attitudes and beliefs regarding the use of deceased family member tissue to guide living family member genetic cancer risk assessment.
Nehoray B, Slavin TP, Sun CL, Hurley K, King E, Tsang KK, Cervantes A, Mokhnatkin JV, Sand S, Mejia R, Reb A, Samimi G, Gray S, Blazer KR, Weitzel JN.
J Genet Couns. 2022 May 26. doi: 10.1002/jgc4.1587. Epub ahead of print.

Source abstract

Perceived risk and risk reduction behaviours of female first-degree relatives of breast cancer patients attending care at Uganda cancer institute.
Ainembabazi P, Abila DB, Manyangwa G, Anguzu G, Musaazi J, Mutyaba I, Osingada CP, Mwaka AD.
Psychooncology. 2022 May 18. doi: 10.1002/pon.5963. Epub ahead of print.

Comparing the attitudes of physicians and non-physicians toward communicating a patient's BRCA1 mutation to a first-degree relative against a patient's wishes.
Zebrack JE, Yang W, Milone M, Coppes MJ.
J Community Genet. 2022 May 21. doi: 10.1007/s12687-022-00591-2. Epub ahead of print.

Breast cancer risk for transgender men with inherited mutations.
[No author given]
FORCE. XRAY. 2022 May 19.

Research news
Free Full Text

Commentary:

BRCA Mutations and the Implications in Transgender Individuals Undergoing Top Surgery: An Operative Dilemma.

Differences in Willingness to Undergo BRCA1/2 Testing and Risk Reducing Surgery among the General Public, Cancer Patients, and Healthcare Professionals: A Large Population-Based Survey.
Chang YJ, Cho S, Joo J, Ryu KH, Lee S, Cho J, Lim MC, Jung SY, Han JH, Lee ES, Kong SY.
J Pers Med. 2022 May 18;12(5):818. doi: 10.3390/jpm12050818.

Source abstract

Free Full Text

LitAlert ~~ GeneLit.com

Healthcare professionals' perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups.
Witjes VM, Braspenning JCC, Hoogerbrugge N, Smolders YHCM, Hermkens DMA, Mourits MJE, Ligtenberg MJL, Ausems MGEM, de Hullu JA.
Fam Cancer. 2022 May 16. doi: 10.1007/s10689-022-00294-0. Epub ahead of print.

PMID: 35570228
PubMed abstract

Free Full Text

Incomplete Penetrance of Population-Based Genetic Screening Results in Electronic Health Record.
Elhanan G, Kiser D, Neveux I, Dabe S, Bolze A, Metcalf WJ, Lu JT, Grzymski JJ.
Front Genet. 2022 Apr 27;13:866169. doi: 10.3389/fgene.2022.866169.

PMID: 35571025
PubMed abstract

A Woman Needs to Know She Is a BRCA Carrier Before She Develops Breast Cancer.
Hughes KS, Yin K.
Ann Surg Oncol. 2022 May 12. doi: 10.1245/s10434-022-11860-2. Epub ahead of print.

PMID: 35552928
PubMed abstract

Commentary
Free Full Text

Making BRCA1 genetic test reports easier to understand through user-centered design: A randomized trial.
Recchia G, Lawrence ACE, Capacchione L, Freeman ALJ.
Genet Med. 2022 May 5:S1098-3600(22)00745-6. doi: 10.1016/j.gim.2022.04.016. Epub ahead of print.

PMID: 35522238
PubMed abstract

Free Full Text

Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: a prospective study.
Brédart A, De Pauw A, Tüchler A, Lakeman IMM, Anota A, Rhiem K, Schmutzler R, van Asperen CJ, Devilee P, Stoppa-Lyonnet D, Kop JL, Dolbeault S.
Clin Genet. 2022 May 4. doi: 10.1111/cge.14147. Epub ahead of print.

LitAlert ~~ GeneLit.com

Effects of diet education on empowerment for individuals who have an increased risk of developing breast or colon cancer: A pilot study.
Tlusty K, Jackson M, Riley B, Blase T.
J Genet Couns. 2022 May 3. doi: 10.1002/jgc4.1584. Epub ahead of print.

Free Full Text

Perceptions and Care Recommendations from Previvors: Qualitative Analysis of Female BRCA1/2 Mutation Carriers’ Experience with Genetic Testing and Counseling.
Dibble KE, Donorfio LKM, Britner PA, Bellizzi KM.
Gynecol Oncol Rep. 2022 May 2;100989. doi: 10.1016/j.gore.2022.100989.

Free Full Text